Coronavirus: Merck files for U.S. approval of its Covid pill
Sylvie Claire / October 11, 2021
The American laboratory Merck announced on Monday that it had filed an application for authorization with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.
The application is for Merck's drug molnupiravir for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and/or hospitalization, the company said in a statement.
Related Posts
Coronavirus - Omicron: patients are not seriously ill for the moment
Sylvie Claire / November 28, 2021
People infected in South Africa with the new variant of the Omicron coronavirus ar...
Read More
The new variant of the coronavirus classified of concern by the WHO and named Omicron
Sylvie Claire / November 27, 2021
The new variant is now called Omicron. Experts mandated by the World Health Organ...
Read More
Coronavirus: Russian Sputnik V vaccine developers claim longer efficacy
Sylvie Claire / November 25, 2021
The developers of Sputnik V said Wednesday that the Russian vaccine was more effe...
Read More